Skip to Main Content

Paper Details

Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys
7
2022
Author NameAffiliation
Rachel M GlicksmanUniversity of Toronto, Princess Margaret Cancer Centre, University Health Network
Antonio FinelliUniversity Health Network, University of Toronto
Neil E FleshnerUniversity Health Network, University of Toronto
Alexandre R ZlottaUniversity Health Network, University of Toronto
Girish S KulkarniUniversity Health Network, University of Toronto
Alejandro BerlinUniversity of Toronto, Princess Margaret Cancer Centre, University Health Network, Canada TECHNA Institute
  • 1 - 6

Datasets

Release 1.2